CLINICAL_TRIALS
trial_result
· 2019-10-28
Clinical Trial Update: Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine [Phase 1, Phase 2]
Summary
Phase 1/2a trial of a Plasmodium falciparum GAP p52/p36 sporozoite malaria vaccine was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seattle Children's Hospital | Conditions: Malaria | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-10-28